Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

NeuroPace (NPCE) Shares Issued (2020 - 2025)

NeuroPace (NPCE) has 6 years of Shares Issued data on record, last reported at $723000.0 in Q4 2025.

  • For Q4 2025, Shares Issued rose 21.51% year-over-year to $723000.0; the TTM value through Dec 2025 reached $1.9 million, down 2.9%, while the annual FY2025 figure was $1.9 million, 2.9% down from the prior year.
  • Shares Issued reached $723000.0 in Q4 2025 per NPCE's latest filing, up from $1000.0 in the prior quarter.
  • Across five years, Shares Issued topped out at $109.1 million in Q2 2021 and bottomed at -$108.2 million in Q4 2021.
  • Average Shares Issued over 5 years is $307111.1, with a median of $139500.0 recorded in 2023.
  • Peak YoY movement for Shares Issued: plummeted 2163500.0% in 2021, then skyrocketed 72000.0% in 2024.
  • A 5-year view of Shares Issued shows it stood at -$108.2 million in 2021, then soared by 99.37% to -$683000.0 in 2022, then soared by 180.38% to $549000.0 in 2023, then rose by 8.38% to $595000.0 in 2024, then increased by 21.51% to $723000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Shares Issued were $723000.0 in Q4 2025, $1000.0 in Q3 2025, and -$2.2 million in Q2 2025.